{"id":50931,"date":"2017-12-18T11:41:50","date_gmt":"2017-12-18T06:11:50","guid":{"rendered":"https:\/\/www.legalindia.com\/news\/?p=50931"},"modified":"2017-12-18T11:41:50","modified_gmt":"2017-12-18T06:11:50","slug":"sc-relook-349-fdc-medicines-drug-advisory-board","status":"publish","type":"post","link":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board","title":{"rendered":"SC for relook into 349 FDC medicines by drug advisory board"},"content":{"rendered":"
\"SC<\/a>
SC for relook into 349 FDC medicines by drug advisory board<\/figcaption><\/figure>\n

Pharmaceutical firms have suffered a setback as the Supreme Court has favoured re- examination of 349 fixed dose combination (FDC) medicines, a ban on which was set aside by the Delhi High Court.<\/p>\n

The FDC medicines, including well-known brands such as Corex cough syrup and Vicks Action 500 Extra and several anti-diabetes drugs, were banned by the Centre on the grounds that they involved “risk” to humans and safer alternatives were available.<\/p>\n

Deciding the appeals of the Centre, a bench of justices R F Nariman and S K Kaul yesterday set aside the high court order, saying that the requisite procedure prescribed in the Drugs and Cosmetics Act were not followed and ordered that these medicines be re-examined by the Drugs Technical Advisory Board (DTAB).<\/p>\n

The Centre had on March 10, 2016 banned the FDC medicines on the recommendations of the Kokate Committee.<\/p>\n

“In order that an analysis be made in greater depth, we, therefore, feel that these cases should go to the DTAB and\/or a sub-committee formed by the DTAB for the purpose of having a relook into these cases,” the apex court said in its verdict.<\/p>\n

It said that THE DTAB or its sub-committee appointed for this purpose would hear the drug manufacturers and also the the submissions from NGO All India Drugs Action Network.<\/p>\n

The top court said that the DTAB\/sub-committee will deliberate on the parameters set out in section 26A (power to prohibit manufacture of drugs and cosmetics in public interest) of the drugs Act like first and foremost in each case, it must satisfy itself that the use of the FDC in question is likely to involve any risk to human beings or animals.<\/p>\n

Secondly, it said the FDCs do not have the therapeutic value claimed or purported to be claimed for them and whether such FDCs contain ingredients and in such quantity for which there is no therapeutic justification.<\/p>\n

It said that the DTAB\/sub-committee must also apply its mind as to whether it is then necessary or expedient, in the larger public interest, to regulate, restrict or prohibit the manufacture, sale or distribution of such FDCs.<\/p>\n

The bench said that the board or committee must clearly indicate in its report as to why, according to it, any one of the three factors are attracted and post such satisfaction, that in the larger public interest, it is necessary or expedient to regulate, restrict, or prohibit the manufacture, sale or distribution of such FDCs.<\/p>\n

The top court said that the DTAB\/Sub-Committee must also indicate as to why, in case it prohibits a particular FDC, restriction or regulation is not sufficient to control the manufacture and use of the FDC.<\/p>\n

“We request the DTAB\/Sub-Committee to be set up for this purpose to afford the necessary hearing to all concerned, and thereafter submit a consolidated report, insofar as these FDCs are concerned, to the central government within a period of six months from the date on which this judgment is received by the DTAB,” it said.<\/p>\n

The Delhi High Court had on December 1, 2016, allowed the petitions of various pharma and healthcare majors, like Pfizer, Glenmark, Procter and Gamble and Cipla challenging the government’s March 10 notification banning the FDCs, saying the decision was taken by the Centre without following procedure prescribed in the Drugs and Cosmetics Act.<\/p>\n

Some of the well-known medicines on which the ban on sale was lifted by the high court included Pfizer’s Corex cough syrup, Glaxo’s Piriton expectorant and Crocin Cold, P&G’s Vicks Action 500 Extra, Reckitt’s D’Cold, Piramal’s Saridon, Glenmark’s Ascoril and Alex cough syrups, Abbott’s Phensedyl cough syrup and Alembic’s Glycodin cough syrup.<\/p>\n

The apex court, however, said that “it will be open for the central government, if it so chooses, de novo, to carry out an inquiry as to whether such drugs should be the subject matter of a notification under Section 26A of the Drugs Act”.<\/p>\n

( Source – PTI )<\/p>\n","protected":false},"excerpt":{"rendered":"

Pharmaceutical firms have suffered a setback as the Supreme Court has favoured re- examination of 349 fixed dose combination (FDC) medicines, a ban on which was set aside by the Delhi High Court. The FDC medicines, including well-known brands such as Corex cough syrup and Vicks Action 500 Extra and several anti-diabetes drugs, were banned […]<\/p>\n","protected":false},"author":1,"featured_media":47555,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1954],"tags":[146,40955,40954,31987,117,80,47726],"class_list":["post-50931","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-high-profile-cases","tag-court","tag-drug-advisory-board","tag-fdc-medicines","tag-featured","tag-law","tag-legal-news","tag-supreme-court"],"yoast_head":"\nSC for relook into 349 FDC medicines by drug advisory board - Legal News India - Supreme Court & High Court Updates<\/title>\n<meta name=\"description\" content=\"Pharmaceutical firms have suffered a setback as the Supreme Court has favoured re- examination of 349 fixed dose combination (FDC) medicines, a ban on - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SC for relook into 349 FDC medicines by drug advisory board - Legal News India - Supreme Court & High Court Updates\" \/>\n<meta property=\"og:description\" content=\"Pharmaceutical firms have suffered a setback as the Supreme Court has favoured re- examination of 349 fixed dose combination (FDC) medicines, a ban on - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board\" \/>\n<meta property=\"og:site_name\" content=\"Legal News India - Supreme Court & High Court Updates\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LegalindiaCom\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-12-18T06:11:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"299\" \/>\n\t<meta property=\"og:image:height\" content=\"169\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Legal India Admin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Legal India Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/sc-relook-349-fdc-medicines-drug-advisory-board#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/sc-relook-349-fdc-medicines-drug-advisory-board\"},\"author\":{\"name\":\"Legal India Admin\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#\\\/schema\\\/person\\\/0bfdffe9059fb8bb24a86d094609c5ea\"},\"headline\":\"SC for relook into 349 FDC medicines by drug advisory board\",\"datePublished\":\"2017-12-18T06:11:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/sc-relook-349-fdc-medicines-drug-advisory-board\"},\"wordCount\":687,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/sc-relook-349-fdc-medicines-drug-advisory-board#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/03\\\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1\",\"keywords\":[\"Court\",\"drug advisory board\",\"FDC medicines\",\"featured\",\"Law\",\"Legal News\",\"Supreme Court\"],\"articleSection\":[\"High Profile Cases\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.legalindia.com\\\/news\\\/sc-relook-349-fdc-medicines-drug-advisory-board#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/sc-relook-349-fdc-medicines-drug-advisory-board\",\"url\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/sc-relook-349-fdc-medicines-drug-advisory-board\",\"name\":\"SC for relook into 349 FDC medicines by drug advisory board - Legal News India - Supreme Court & High Court Updates\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/sc-relook-349-fdc-medicines-drug-advisory-board#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/sc-relook-349-fdc-medicines-drug-advisory-board#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/03\\\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1\",\"datePublished\":\"2017-12-18T06:11:50+00:00\",\"description\":\"Pharmaceutical firms have suffered a setback as the Supreme Court has favoured re- examination of 349 fixed dose combination (FDC) medicines, a ban on - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/sc-relook-349-fdc-medicines-drug-advisory-board#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.legalindia.com\\\/news\\\/sc-relook-349-fdc-medicines-drug-advisory-board\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/sc-relook-349-fdc-medicines-drug-advisory-board#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/03\\\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/03\\\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1\",\"width\":299,\"height\":169},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/sc-relook-349-fdc-medicines-drug-advisory-board#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"High Profile Cases\",\"item\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/category\\\/high-profile-cases\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"SC for relook into 349 FDC medicines by drug advisory board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/\",\"name\":\"Legal News India - Supreme Court & High Court Updates\",\"description\":\"Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#organization\"},\"alternateName\":\"Legal News India for Advocates, Lawyers & Law Students\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#organization\",\"name\":\"Legal News India: Supreme Court, High Courts & Govt Updates\",\"alternateName\":\"Legal News India for Advocates, Lawyers & Law Students\",\"url\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2018\\\/05\\\/538552_367793346590451_81997783_n.jpg?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2018\\\/05\\\/538552_367793346590451_81997783_n.jpg?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"Legal News India: Supreme Court, High Courts & Govt Updates\"},\"image\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/LegalindiaCom\\\/\",\"https:\\\/\\\/x.com\\\/Legal_india\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#\\\/schema\\\/person\\\/0bfdffe9059fb8bb24a86d094609c5ea\",\"name\":\"Legal India Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g\",\"caption\":\"Legal India Admin\"},\"sameAs\":[\"https:\\\/\\\/www.legalindia.com\",\"https:\\\/\\\/x.com\\\/legaliadmin\"],\"url\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/author\\\/legal-india-admin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SC for relook into 349 FDC medicines by drug advisory board - Legal News India - Supreme Court & High Court Updates","description":"Pharmaceutical firms have suffered a setback as the Supreme Court has favoured re- examination of 349 fixed dose combination (FDC) medicines, a ban on - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board","og_locale":"en_US","og_type":"article","og_title":"SC for relook into 349 FDC medicines by drug advisory board - Legal News India - Supreme Court & High Court Updates","og_description":"Pharmaceutical firms have suffered a setback as the Supreme Court has favoured re- examination of 349 fixed dose combination (FDC) medicines, a ban on - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.","og_url":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board","og_site_name":"Legal News India - Supreme Court & High Court Updates","article_publisher":"https:\/\/www.facebook.com\/LegalindiaCom\/","article_published_time":"2017-12-18T06:11:50+00:00","og_image":[{"width":299,"height":169,"url":"https:\/\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg","type":"image\/jpeg"}],"author":"Legal India Admin","twitter_misc":{"Written by":"Legal India Admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board#article","isPartOf":{"@id":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board"},"author":{"name":"Legal India Admin","@id":"https:\/\/www.legalindia.com\/news\/#\/schema\/person\/0bfdffe9059fb8bb24a86d094609c5ea"},"headline":"SC for relook into 349 FDC medicines by drug advisory board","datePublished":"2017-12-18T06:11:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board"},"wordCount":687,"commentCount":0,"publisher":{"@id":"https:\/\/www.legalindia.com\/news\/#organization"},"image":{"@id":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1","keywords":["Court","drug advisory board","FDC medicines","featured","Law","Legal News","Supreme Court"],"articleSection":["High Profile Cases"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board","url":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board","name":"SC for relook into 349 FDC medicines by drug advisory board - Legal News India - Supreme Court & High Court Updates","isPartOf":{"@id":"https:\/\/www.legalindia.com\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board#primaryimage"},"image":{"@id":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1","datePublished":"2017-12-18T06:11:50+00:00","description":"Pharmaceutical firms have suffered a setback as the Supreme Court has favoured re- examination of 349 fixed dose combination (FDC) medicines, a ban on - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.","breadcrumb":{"@id":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board#primaryimage","url":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1","width":299,"height":169},{"@type":"BreadcrumbList","@id":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.legalindia.com\/news\/"},{"@type":"ListItem","position":2,"name":"High Profile Cases","item":"https:\/\/www.legalindia.com\/news\/category\/high-profile-cases"},{"@type":"ListItem","position":3,"name":"SC for relook into 349 FDC medicines by drug advisory board"}]},{"@type":"WebSite","@id":"https:\/\/www.legalindia.com\/news\/#website","url":"https:\/\/www.legalindia.com\/news\/","name":"Legal News India - Supreme Court & High Court Updates","description":"Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.","publisher":{"@id":"https:\/\/www.legalindia.com\/news\/#organization"},"alternateName":"Legal News India for Advocates, Lawyers & Law Students","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.legalindia.com\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.legalindia.com\/news\/#organization","name":"Legal News India: Supreme Court, High Courts & Govt Updates","alternateName":"Legal News India for Advocates, Lawyers & Law Students","url":"https:\/\/www.legalindia.com\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.legalindia.com\/news\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2018\/05\/538552_367793346590451_81997783_n.jpg?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2018\/05\/538552_367793346590451_81997783_n.jpg?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"Legal News India: Supreme Court, High Courts & Govt Updates"},"image":{"@id":"https:\/\/www.legalindia.com\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LegalindiaCom\/","https:\/\/x.com\/Legal_india"]},{"@type":"Person","@id":"https:\/\/www.legalindia.com\/news\/#\/schema\/person\/0bfdffe9059fb8bb24a86d094609c5ea","name":"Legal India Admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g","caption":"Legal India Admin"},"sameAs":["https:\/\/www.legalindia.com","https:\/\/x.com\/legaliadmin"],"url":"https:\/\/www.legalindia.com\/news\/author\/legal-india-admin"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":45988,"url":"https:\/\/www.legalindia.com\/news\/delhi-hc-quashes-ban-344-fixed-dose-combo-medicines","url_meta":{"origin":50931,"position":0},"title":"Delhi HC quashes ban on 344 fixed dose combo medicines","author":"Legal India News","date":"December 1, 2016","format":false,"excerpt":"In a blow to the Centre, its decision to ban 344 fixed dose combination (FDC) medicines, including well known brands like Corex cough syrup, Vicks Action 500 extra and several anti-diabetes medication, was today set aside by the Delhi High Court which said the step was taken in a \"haphazard\u2026","rel":"","context":"In "Top Law News"","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"Delhi HC quashes ban on 344 fixed dose combo medicines","src":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2016\/08\/Law-300x200.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":27517,"url":"https:\/\/www.legalindia.com\/news\/sc-rejects-plea-of-novartis-for-patent-of-glivec-drug","url_meta":{"origin":50931,"position":1},"title":"SC rejects plea of Novartis for patent of Glivec drug","author":"Legal India Admin","date":"April 2, 2013","format":false,"excerpt":"The\u00a0Supreme Court cleared the decks for Indian drug manufacturing companies to make available life saving medicines to patients in India at a cheaper rate, by coming to the rescue of cancer patients. A bench comprising Justices Aftab Alam and Ranjana Prakash Desai dismissed a petition of Swiss pharma giant Novartis\u2026","rel":"","context":"In "Top Law News"","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":33933,"url":"https:\/\/www.legalindia.com\/news\/invite-bids-cghs-medicines-brand-hc","url_meta":{"origin":50931,"position":2},"title":"Why invite bids for CGHS medicines by brand: HC","author":"Legal India Admin","date":"June 30, 2014","format":false,"excerpt":"The Delhi High Court has asked the Centre reasons for inviting bids for supply of CGHS medicines from drug manufacturers on the basis of brand names instead of their chemical composition and sought an explanation from the government. \"Why not go by composition,\" a vacation bench of justices Pratibha Rani\u2026","rel":"","context":"In "Top Law News"","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"medicines","src":"https:\/\/i0.wp.com\/www.legalindia.in\/news\/wp-content\/uploads\/2014\/06\/medicines.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":23856,"url":"https:\/\/www.legalindia.com\/news\/medicines-should-be-within-reach-of-common-man-sc","url_meta":{"origin":50931,"position":3},"title":"Medicines should be within reach of common man: SC","author":"Legal India Admin","date":"October 4, 2012","format":false,"excerpt":"Protecting the interest of the common man, the Supreme Court Wednesday told the government not to disturb the existing retail price mechanism of drugs under the price control order while finalising the list of essential medicines. The judges observed that the prices of the drugs were so high that it\u2026","rel":"","context":"In "Top Law News"","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":57658,"url":"https:\/\/www.legalindia.com\/news\/circulated-order-staying-online-sale-of-medicines-to-states-centre","url_meta":{"origin":50931,"position":4},"title":"Circulated order staying online sale of medicines to states: Centre","author":"Legal India Admin","date":"September 26, 2019","format":false,"excerpt":"The Centre told the Delhi High Court Tuesday that it has informed all state drug controlling authorities about the interim order barring online sale of medicines and has directed them to take requisite action under the Drugs and Cosmetics (D&C) Act and Rules. The submission was made before a bench\u2026","rel":"","context":"In "Top Law News"","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2019\/09\/medicines.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":23989,"url":"https:\/\/www.legalindia.com\/news\/decision-on-new-drug-pricing-policy-by-mid-november","url_meta":{"origin":50931,"position":5},"title":"Decision on new drug pricing policy by mid-November","author":"Legal India Admin","date":"October 11, 2012","format":false,"excerpt":"The central government Thursday told the Supreme Court that it would decide on the new National Pharmaceutical Pricing Policy by mid-November and the same would be notified in the week thereafter. The court said it should not trigger any hike in the price of drugs in the market. Appearing for\u2026","rel":"","context":"In "Top Law News"","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_shortlink":"https:\/\/wp.me\/p6H5Bf-dft","jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/posts\/50931","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/comments?post=50931"}],"version-history":[{"count":0,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/posts\/50931\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/media\/47555"}],"wp:attachment":[{"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/media?parent=50931"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/categories?post=50931"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/tags?post=50931"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}